Afya in early talks on potential Yduqs deal

Afya Ltd (AFYA) reports that it is in early-stage discussions with Yduqs Participações S.A. regarding a potential business combination involving the two companies.

Rhea-AI Filing Summary

Afya Ltd (AFYA) reports that it is in early-stage discussions with Yduqs Participações S.A. regarding a potential business combination involving the two companies. Afya highlights that, as of now, no binding agreement, contract, commitment, or obligation has been entered into by either party or their shareholders or management teams.

The company emphasizes that there can be no assurance these preliminary discussions will lead to any agreement or transaction. Afya states it does not intend to comment further on the matter unless required by applicable law or if its Board considers additional disclosure appropriate, and it will inform shareholders of any material developments in line with U.S. securities laws and Nasdaq rules.

Key Terms

business combination, material fact, CVM Resolution No. 44/2021

3 terms

business combination financial

"regarding a potential business combination involving the two companies"

A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

material fact regulatory

"following the material fact disclosed by Yduqs on this date"

Information or an event that a reasonable investor would consider important when deciding to buy, sell or hold a security; it changes the expected value, risk, or outlook of an investment. Regulators treat material facts as disclosures that companies must share publicly because they can affect market prices, similar to a key ingredient in a recipe that determines the final taste. It matters to investors because material facts can change the basis for an investment decision and move trading activity and prices.

CVM Resolution No. 44/2021 regulatory

"pursuant to Article 157, Paragraph 4 of Brazilian Law No. 6,404/1976 and CVM Resolution No. 44/2021"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What potential transaction did Afya Ltd (AFYA) disclose with Yduqs Participações S.A.?

Afya disclosed that it is in early-stage discussions with Yduqs Participações S.A. about a potential business combination involving the two companies. Afya stated that there is currently no binding agreement, contract, or commitment related to any such transaction.

Has Afya Ltd (AFYA) signed any agreement with Yduqs regarding the potential business combination?

No. Afya stated that no binding agreement, contract, or commitment has been entered into by Afya, Yduqs, or their respective shareholders or management teams in connection with any potential transaction.

Can investors assume that the Afya (AFYA) and Yduqs discussions will result in a deal?

No. Afya noted that the discussions are at an early stage and that there can be no assurance they will result in any agreement or transaction between the companies.

How does Afya Ltd (AFYA) plan to communicate further about the potential business combination?

Afya stated it does not intend to comment further on the matter unless further disclosure is required by applicable law or its Board determines additional disclosure is appropriate. It will keep shareholders informed of any material developments under U.S. securities laws and Nasdaq rules.

What did Afya Ltd (AFYA) say about Yduqs’s prior disclosure on the potential combination?

Afya referenced that Yduqs had disclosed a material fact about the potential business combination pursuant to Article 157, Paragraph 4 of Brazilian Law No. 6,404/1976 and CVM Resolution No. 44/2021, and reiterated that discussions remain at an early stage.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 08:51 AM EDT Accepted by SEC EDGAR 08/24/2026 - 08:51 AM EDT Learn about SEC filing dates

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August, 2026

 Commission File Number: 001-38992

Afya Limited

(Exact name of registrant as specified in its charter)

Rua Paraíba, No. 330, 17º Andar, CEP 30130-917

Bairro Funcionários, Belo Horizonte, Minas Gerais

Brazil

+55 (31) 3515 7550

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

TABLE OF CONTENTS

EXHIBIT
99.1	Afya Limited comments on recent public disclosure made by Yduqs Participações S.A. regarding a potential business combination

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Afya Limited
			By:	/s/ Virgilio Deloy Capobianco Gibbon
				Name:	Virgilio Deloy Capobianco Gibbon
				Title:	Chief Executive Officer

Date: August 24, 2026

Afya Limited comments on recent public disclosure made by Yduqs Participações S.A. regarding a potential business combination

Belo Horizonte, Minas Gerais, Brazil, August 24, 2026 – Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that discussions with Yduqs Participações S.A. (B3: YDUQ3) ("Yduqs") regarding a potential business combination involving the two companies are at an early stage, following the material fact disclosed by Yduqs on this date, pursuant to Article 157, Paragraph 4 of Brazilian Law No. 6,404/1976 and CVM Resolution No. 44/2021.

As disclosed by Yduqs, these discussions remain at an early stage, and there can be no assurance that they will result in any agreement or transaction. To date, no binding agreement, contract, or commitment has been entered into, nor has any obligation been assumed, by Afya, Yduqs, or any of their respective shareholders or management teams in connection with any potential transaction.

Afya does not intend to comment further on this matter unless and until further disclosure is required by applicable law or the Company's Board determines that further disclosure is appropriate. The Company will keep its shareholders and the market informed of any material developments, in accordance with applicable U.S. securities laws and Nasdaq rules.

About Afya Limited

Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career.

Contact:

Investor Contact: ir@afya.com.br

IR Website: ir.afya.com.br

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 3.4 KB